Fritextsökning
Innehållstyper
-
Neanderthal genes and Nobel Prize in a popular lecture at Bioscience
An inherited gene variant from our ”evolutionary cousins” – the extinct Neanderthals – may affect how our bodies break down certain drugs. “It’s only a matter o...
-
The fast route to a safe insulin pen
Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...
-
Anna Törner: Kalashnikovs in a new guise
Thanks to resisting European regulatory authorities, Europe has been spared the opioid epidemic. In the 1960s, the situation was the opposite as the American ph...
-
The first drugs to slow down Alzheimer’s – but what does it mean for patients?
New treatments for early Alzheimer’s are bringing hope to thousands of patients and their families. The question is, who will get the treatment, how will the ri...
-
Analytisk kemi nytt ben för Recipharm
CDMO Recipharm lanserar en fristående tjänst inom analytisk kemi.
-
Business Sweden’s new team is rolling out the blue-yellow carpet
According to Business Sweden’s life science team, the combination of substantial medical know-how and an ever-flourishing tech sector is a success factor for Sw...
-
Collaboration in laboratory automation
The Dutch company Synchron Lab Automation developed an automated DNA extraction system with high throughput, working very closely together with Festo. As a resu...
-
Marie Gårdmark: Finally, it’s time for a revision of the EU pharma legislation
A challenge for the EU Commission is to deliver a new framework that will also take care of another “pillar” of the pharmaceutical strategy, namely, to ensure t...
-
Add Bio får tre nya ägare
Tar in 9,4 miljoner kronor i nyemission.
-
Giulia Gaudenzi: ”Key lessons from global health research”
The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.
-
Delivering drugs with small devices
There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct s...
-
Dålig rapportering av läkares relation till industrin
Sverige bland de sämsta länderna, visar ny studie.
-
How to become globally competitive
Here Gunilla Osswald from BioArctic share her experience of scaling up and be competative on the global arena.
-
Swedish Healthtech Company 1928 Pushing Forward
The full service analytics platform is expanding the business.
-
Norway finds its path in life science
The life science sector in Norway is on the rise.
-
From spin-off to phase II
”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.
-
Oasmia får ny ordförande
Karo Pharmas ordförande Anders Lönner föreslås även leda Oasmias styrelse i samband med en ny affär mellan bolagen.
-
Before you choose a CRO
– We are a small company and it is very important for us to maintain our core competence within development of novel nanomaterials, Tove Sivik Sonne, Head of De...
-
Rustar inför exit
Synthetic MR får en ny styrelsetopp lagom till avknoppningen från Accelerator.
-
Bought a tablet factory – and built his own empire
In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move i...
-
Fäster bättre med behandlad yta
Add Bio visar positiva resultat med tandimplantat i klinik.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
BREAKING